Annual Current Liabilities
$111.09 M
+$36.71 M+49.36%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual total current liabilities is $111.09 million, with the most recent change of +$36.71 million (+49.36%) on December 31, 2022.
- During the last 3 years, EGRX annual current liabilities has risen by +$72.26 million (+186.14%).
- EGRX annual current liabilities is now at all-time high.
Performance
EGRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$86.63 M
-$11.18 M-11.43%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly total current liabilities is $86.63 million, with the most recent change of -$11.18 million (-11.43%) on June 30, 2023.
- Over the past year, EGRX quarterly current liabilities has dropped by -$22.33 million (-20.50%).
- EGRX quarterly current liabilities is now -40.62% below its all-time high of $145.88 million, reached on March 31, 2020.
Performance
EGRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
EGRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.4% | -20.5% |
| 3 y3 years | +186.1% | +114.0% |
| 5 y5 years | +134.8% | +81.5% |
EGRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.4% | -28.9% | +16.5% |
| 5 y | 5-year | at high | +191.7% | -40.6% | +127.5% |
| alltime | all time | at high | +674.6% | -40.6% | +504.0% |
Eagle Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $86.63 M(-11.4%) |
| Mar 2023 | - | $97.81 M(-12.0%) |
| Dec 2022 | $111.09 M(+49.4%) | $111.09 M(-8.8%) |
| Sep 2022 | - | $121.83 M(+11.8%) |
| Jun 2022 | - | $108.96 M(+7.2%) |
| Mar 2022 | - | $101.64 M(+36.7%) |
| Dec 2021 | $74.38 M(+95.3%) | $74.38 M(+53.6%) |
| Sep 2021 | - | $48.43 M(+8.4%) |
| Jun 2021 | - | $44.66 M(+6.4%) |
| Mar 2021 | - | $41.97 M(+10.2%) |
| Dec 2020 | $38.09 M(-1.9%) | $38.09 M(-16.3%) |
| Sep 2020 | - | $45.51 M(+12.4%) |
| Jun 2020 | - | $40.49 M(-72.2%) |
| Mar 2020 | - | $145.88 M(+275.8%) |
| Dec 2019 | $38.82 M(-2.2%) | $38.82 M(-8.3%) |
| Sep 2019 | - | $42.36 M(-18.1%) |
| Jun 2019 | - | $51.75 M(+17.0%) |
| Mar 2019 | - | $44.22 M(+11.4%) |
| Dec 2018 | $39.69 M | $39.69 M(+12.1%) |
| Sep 2018 | - | $35.41 M(-25.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $47.74 M(+66.0%) |
| Mar 2018 | - | $28.76 M(-39.2%) |
| Dec 2017 | $47.30 M(+15.5%) | $47.30 M(+37.5%) |
| Sep 2017 | - | $34.40 M(+7.6%) |
| Jun 2017 | - | $31.95 M(-9.8%) |
| Mar 2017 | - | $35.44 M(-13.5%) |
| Dec 2016 | $40.97 M(+19.6%) | $40.97 M(+15.6%) |
| Sep 2016 | - | $35.45 M(-0.9%) |
| Jun 2016 | - | $35.78 M(+15.9%) |
| Mar 2016 | - | $30.87 M(-9.9%) |
| Dec 2015 | $34.26 M(+68.7%) | $34.26 M(-0.9%) |
| Sep 2015 | - | $34.59 M(+40.7%) |
| Jun 2015 | - | $24.58 M(-9.1%) |
| Mar 2015 | - | $27.05 M(+21.9%) |
| Dec 2014 | - | $22.19 M(+9.2%) |
| Sep 2014 | $20.32 M(+41.6%) | $20.32 M(+25.0%) |
| Jun 2014 | - | $16.25 M(-15.7%) |
| Mar 2014 | - | $19.27 M(+11.8%) |
| Dec 2013 | - | $17.24 M(+20.2%) |
| Sep 2013 | $14.34 M(-31.3%) | $14.34 M |
| Sep 2012 | $20.88 M | - |
FAQ
- What is Eagle Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual current liabilities year-on-year change?
- What is Eagle Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly current liabilities year-on-year change?
What is Eagle Pharmaceuticals annual total current liabilities?
The current annual current liabilities of EGRX is $111.09 M
What is the all time high annual current liabilities for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual total current liabilities is $111.09 M
What is Eagle Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, EGRX annual total current liabilities has changed by +$36.71 M (+49.36%)
What is Eagle Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of EGRX is $86.63 M
What is the all time high quarterly current liabilities for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly total current liabilities is $145.88 M
What is Eagle Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, EGRX quarterly total current liabilities has changed by -$22.33 M (-20.50%)